November 2022

Press Release TEL AVIV, Israel & MELBOURNE, Australia, November 21, 2022 – Azura Ophthalmics Ltd., a clinical-stage biopharmaceutical company developing a new therapeutic class of Ophthalmic Keratolytics for ocular surface diseases, today announced that members of management will present at BTIG’s Ophthalmology Day 2022, being held on November 29, and at the Piper Sandler 34th […]

Press Release — AZR-MD-001 0.5% meets co-primary efficacy endpoints, making it the first investigational drug to show significant improvements in both signs and symptoms of Meibomian Gland Dysfunction — — Restoration of gland function shown to improve downstream response measures of ocular conditions associated with Meibomian Gland Dysfunction — — Rapidly advancing AZR-MD-001 to Phase